Irit Van-Ham

Irit Van-Ham has over 25 years of professional experience across various industries. Irit is the founder and CTO of ToeFx, a medical device company focused on developing a treatment for nail fungus. Prior to this, they were the founder and CEO of Olliane Ltd., a personalized skincare company. Irit has also worked as a toxicology, environmental health, and regulation consultant, specializing in the field of toxicology. Irit Van-Ham has held positions as a toxicology specialist at the Ontario Ministry of Health and Long-Term Care and Arcadis. Irit has conducted research as a postdoctoral fellow at the University of Ottawa and worked as a project manager in R&D at Teva Pharmaceuticals.

Irit Van-Ham holds a Doctor of Philosophy (PhD) degree in Medical School, specializing in the field of Pharmacology & Physiology. Irit completed their PhD at Tel Aviv University. Additionally, they also earned a Master of Science (MSc) degree in Biochemistry from Tel Aviv University's Medical School. The specific start and end years for their education were not provided.